In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 John T Parissis
Speaker
John T Parissis
John T Parissis John T Parissis

Attikon University Hospital, Athens (Greece)

Speciality : Acute Heart Failure

36 presentations from this speaker

Inotrope and inodilators - differential effects in acute heart failure and cardiogenic shock.

Event : HFA Discoveries 2020

  • Session : Inotropes and Inodilators in Acute and Advanced Heart Failure
  • Speaker : JT Parissis (Athens,GR)
  • Sponsored by Orion Pharma

Inotropes and Inodilators in Acute and Advanced Heart Failure.

Event : HFA Discoveries 2020

  • Session : Inotropes and Inodilators in Acute and Advanced Heart Failure
  • Speaker : Z Papp (Debrecen,HU), JT Parissis (Athens,GR), B Vrtovec (Ljubljana,SI), G Polzl (Innsbruck,AT)
  • Sponsored by Orion Pharma

Case 1: renin-angiotensin-aldosterone system inhibitors in a patient with chronic kidney disease

Event : ESC Congress 2019

  • Session : Meet the Experts - Heart failure drug therapy in patients with co-morbidities
  • Speaker : JT Parissis (Athens,GR)

Medical therapy.

Event : Heart Failure 2019

  • Session : Cardiogenic shock: recent advances and future perspectives
  • Speaker : JT Parissis (Athens,GR)

Take home message: I.V. Inodilators: why, when and how

Event : ESC Congress 2019

  • Session : I.V. Inodilators: why, when and how?
  • Speaker : JT Parissis (Athens,GR)
  • Sponsored by Orion Pharma

A patient with sepsis - What do the guidelines say?

Event : Heart Failure 2018

  • Session : Guidelines in daily practice II - Acute heart failure
  • Speaker : JT Parissis (Athens,GR)

Association of intra-abdominal pressure changes with early diuretic response and improvement of dyspnea in patients with acute heart failure

Event : ESC Congress 2018

  • Session : Acute heart failure – Pathophysiology and mechanisms
  • Speaker : JT Parissis (Athens,GR)

How to use inotropes and vasodilators in acute heart failure

Event : ESC Congress 2018

  • Session : Expert Advice - Management of acute heart failure in the emergency room
  • Speaker : JT Parissis (Athens,GR)

Inotropes or inodilators in HFrEF: what to use, on whom, when and how? Clinical practice.

Event : Heart Failure 2018

  • Session : Inotropes or inodilators in HFrEF: what to use, on whom, when and how?
  • Speaker : JT Parissis (Athens,GR)
  • Sponsored by Orion Pharma

Inotropes or inodilators in HFrEF: what to use, on whom, when and how? Clinical practice.

Event : Heart Failure 2018

  • Session : Inotropes or inodilators in HFrEF: what to use, on whom, when and how?
  • Speaker : JT Parissis (Athens,GR)
  • Sponsored by Orion Pharma

Inotropes-vasopressors

Event : Heart Failure 2018

  • Session : Cardiogenic shock
  • Speaker : JT Parissis (Athens,GR)

New evidence that has emerged since the guidelines were published.

Event : ESC Congress 2018

  • Session : Guidelines in Daily Practice - Heart failure
  • Speaker : JT Parissis (Athens,GR)
  • Organised with the Hellenic Society of Cardiology

Acute and advanced heart failure.

Event : Heart Failure 2017

  • Session : Heart Failure 2017 Highlights
  • Speaker : JT Parissis (Athens,GR)

Impact on organ failure.

Event : Heart Failure 2017

  • Session : The right ventricle: the bright side of the moon
  • Speaker : JT Parissis (Athens,GR)

The meaning and value of inflammatory markers in acute heart failure

Event : ESC Congress 2017

  • Session : How to interpret laboratory tests in acute heart failure
  • Speaker : JT Parissis (Athens,GR)

What do the Guidelines say?

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice IV: comorbidities - valvular and kidney disease
  • Speaker : JT Parissis (Athens,GR)

A case of decompensated chronic heart failure - What do the Guidelines say?

Event : ESC Congress 2016

  • Session : 2016 Heart failure Guidelines in Greece
  • Speaker : JT Parissis (Athens,GR)

Inotropes.

Event : Heart Failure 2016

  • Session : Novel heart failure therapies
  • Speaker : JT Parissis (Athens,GR)

LVEF 37% and fully treated, increase heart rate, increased BNP, and QRS of 141ms - What to do? Conclusion and take home message

Event : ESC Congress 2016

  • Session : Common difficult decisions in heart failure
  • Speaker : JT Parissis (Athens,GR)

Management of the early phase.

Event : Heart Failure 2016

  • Session : The new ESC Guidelines: Focus on acute heart failure
  • Speaker : JT Parissis (Athens,GR)

Panel discussion on optimizing heart failure care.

Event : Heart Failure 2016

  • Session : Optimizing heart failure care: if not now, when?
  • Speaker : JT Parissis (Athens,GR)
  • Sponsored by SERVIER

Clinical value of inotropes.

Event : Heart Failure 2015

  • Session : Clinical fundamentals of systolic and diastolic function
  • Speaker : JT Parissis (Athens,GR)

Discussion: MOOD-HF.

Event : Heart Failure 2015

  • Session : Late Breaking Trials II: Heart failure management
  • Speaker : JT Parissis (Athens,GR)

Focus on inotropes.

Event : ESC Congress 2015

  • Session : Tips & tricks on how to treat acute heart failure
  • Speaker : JT Parissis (Athens,GR)

Levosimendan clinical use, patient quality of life.

Event : Heart Failure 2015

  • Session : The patient perspective - Effects of levosimendan on hemodynamics and quality of life
  • Speaker : JT Parissis (Athens,GR)
  • Sponsored by Orion Pharma

Liver dysfunction.

Event : Heart Failure 2015

  • Session : Clinical fundamentals of multiple organ dysfunction
  • Speaker : JT Parissis (Athens,GR)

Prognostic value of galectin-3 in adult patients with congenital heart disease

Event : Heart Failure 2015

  • Session : Biomarkers
  • Speaker : JT Parissis (Athens,GR)

Reasons for hospitalisation and rehospitalisation among Greek patients admitted for acute heart failure

Event : Heart Failure 2015

  • Session : Population studies / Epidemiology
  • Speaker : JT Parissis (Athens,GR)

The cost of acute heart failure in Greece: a social security system perspective

Event : Heart Failure 2015

  • Session : Population studies / Epidemiology
  • Speaker : JT Parissis (Athens,GR)

Epidemiology and pathophysiology.

Event : ESC Congress 2014

  • Session : The ongoing challenge of cardiogenic shock
  • Speaker : JT Parissis (Athens,GR)

Body mass index and disease-modifying therapy in acute heart failure patients

Event : ESC Congress 2013

  • Session : Rapid Fire - Acute heart failure: addressing unmet needs
  • Speaker : JT Parissis (Athens,GR)

Epidemiology and pathophysiology.

Event : ESC Congress 2013

  • Session : Management of cardiogenic shock
  • Speaker : JT Parissis (Athens,GR)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are